This trial is testing a new testing platform as developed by Drexel which is studying the improvement in testing times with this new technology.
To learn more about this trial, call the Reading Hospital Cancer Research Office at 484-628-8193.
DREXEL - SEPSIS
A Clinical Trial to Test a Combined ApoH-Drexel Trans-Pan-Domain Molecular Diagnostic for the Species-specific Diagnosis of Sepsis and Blood Stream Infections (BSI)
